QFRIA Trademark

Trademark Overview


On Wednesday, November 23, 2022, a trademark application was filed for QFRIA with the United States Patent and Trademark Office. The USPTO has given the QFRIA trademark a serial number of 97690355. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, August 27, 2024. This trademark is owned by Bristol-Myers Squibb Company. The QFRIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of cancer, auto-immune diseases, leukemia, lymphoma, multiple myeloma, autoinflammatory disease and tumors; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer and cytokine inhibitory drugs; pharmaceutical and biological preparations for human use for immunotherapy, namely, T cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use, all the foregoing excluding pharmaceutical preparations for the treatment of hemophilia
qfria

General Information


Serial Number97690355
Word MarkQFRIA
Filing DateWednesday, November 23, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of cancer, auto-immune diseases, leukemia, lymphoma, multiple myeloma, autoinflammatory disease and tumors; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer and cytokine inhibitory drugs; pharmaceutical and biological preparations for human use for immunotherapy, namely, T cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use, all the foregoing excluding pharmaceutical preparations for the treatment of hemophilia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Monday, November 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 8, 2023ASSIGNED TO EXAMINER
Thursday, March 16, 2023NON-FINAL ACTION WRITTEN
Thursday, March 16, 2023NON-FINAL ACTION E-MAILED
Thursday, March 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 26, 2022NEW APPLICATION ENTERED
Tuesday, June 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 18, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, November 17, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, December 26, 2023ASSIGNED TO PETITION STAFF
Thursday, February 1, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, March 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 27, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 27, 2024SOU EXTENSION 1 GRANTED
Tuesday, August 27, 2024SOU EXTENSION 1 FILED
Saturday, December 30, 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED